This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
electric-vehicles: Archive
Tesla's Optimus and AI Ambitions: Can Musk's Vision Deliver?
by Rimmi Singhi
Tesla pushes ahead with Optimus robots and custom AI chips, but 2025 progress looks more like small steps than breakthroughs.
AMDNegative Net Change NVDANegative Net Change TSLAPositive Net Change
artificial-intelligence automation autonomous-vehicles electric-vehicles robotics tech-stocks
Two Months Into Tesla's Robotaxi Launch: Where Does It Stand Now?
by Rimmi Singhi
Tesla's robotaxi rollout shows early progress in Austin, but regulatory hurdles and strong rivals keep its bold vision in check.
BIDUPositive Net Change TSLAPositive Net Change GOOGLNegative Net Change
autonomous-vehicles electric-vehicles
Polaris Inc (PII) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PIINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Wex (WEX)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
WEXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will Entry Into New Markets Unlock New Growth Drivers for NIO?
by Zacks Equity Research
NIO targets Singapore, Uzbekistan, and Costa Rica with new partnerships and brand rollouts to accelerate its global EV expansion.
NIOPositive Net Change BYDDYPositive Net Change
auto-tires-trucks electric-vehicles
Should You Buy LendingClub (LC) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
LCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Williams-Sonoma (WSM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
WSMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Sally Beauty (SBH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SBHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tesla's 10X P/S Premium: Is the Stock a Buy, Hold or Sell Now?
by Rimmi Singhi
TSLA's steep sales decline, shrinking margins and intensifying competition cast doubt on its lofty 10X sales premium.
TSLAPositive Net Change GOOGLNegative Net Change BYDDYPositive Net Change
auto-tires-trucks autonomous-vehicles electric-vehicles tech-stocks
Can Tesla's New Model Y L Boost its Sales Volumes in China?
by Rimmi Singhi
TSLA launches the six-seat Model Y L in China to regain ground as sales slip and competition from local players rises.
TSLAPositive Net Change NIOPositive Net Change BYDDYPositive Net Change LINegative Net Change
electric-vehicles
Lucid Stock Plunges 22.7% in a Month: Should You Buy, Sell or Hold?
by Lavina Shahu
LCID shares decline 22.7% in a month despite record deliveries and a new Uber robotaxi deal, raising tough questions for investors.
TSLAPositive Net Change UBERNegative Net Change LCIDPositive Net Change RIVNPositive Net Change
auto-tires-trucks electric-vehicles
Should You Buy Dorman Products (DORM) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
DORMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy TPG RE Finance Trust (TRTX) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TRTXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will VWAGY's Backing Turn QS Into a Battery Powerhouse?
by Rimmi Singhi
Volkswagen's partnership with QuantumScape and milestone-based funding could extend QS' runway and accelerate solid-state battery scaling.
SESNegative Net Change VWAGYNegative Net Change QSNegative Net Change SLDPNegative Net Change
auto-tires-trucks batteries electric-vehicles
Is Cobra the Growth Engine That Can Drive QuantumScape Higher?
by Rimmi Singhi
QS' Cobra separator promises faster and cheaper battery production, marking a key step toward commercial scale in the EV race.
SESNegative Net Change QSNegative Net Change SLDPNegative Net Change
auto-tires-trucks batteries electric-vehicles
Should You Buy Mettler-Toledo (MTD) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
MTDPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will Uber's $300M Bet on Gravity Accelerate Lucid's Growth?
by Zacks Equity Research
LCID partners with Uber and Nuro on a $300M robotaxi deal, aiming to deploy 20,000 Gravity EVs in global markets.
TSLAPositive Net Change GOOGLNegative Net Change UBERNegative Net Change LCIDPositive Net Change
auto-tires-trucks electric-vehicles
Newmark Group (NMRK)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
NMRKNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Maximus (MMS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MMSNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Phinia (PHIN)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PHINNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will Domestic Partnerships Secure Lucid's Supply Chain Future?
by Zacks Equity Research
LCID ramps up U.S. sourcing deals with graphite, nickel, and manganese suppliers to strengthen its EV supply chain resilience.
GMNegative Net Change LCIDPositive Net Change RIVNPositive Net Change
auto-tires-trucks electric-vehicles
Is Lucid Ready to Deliver on Its 2026 Midsize EV Launch?
by Zacks Equity Research
LCID targets late-2026 production for its midsize EV platform, aiming for lower costs, faster timelines, and a $50K entry price.
TSLAPositive Net Change LCIDPositive Net Change RIVNPositive Net Change
auto-tires-trucks electric-vehicles
After Golden Cross, Brink's (BCO)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
BCONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Janus Henderson Group plc (JHG) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
JHGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Ford Stock Worth Buying Now on its EV Strategy Shift?
by Rimmi Singhi
F is betting big on a $30K electric pickup and streamlined U.S. battery production to revive its EV fortunes amid fierce global competition.
FNegative Net Change GMNegative Net Change TSLAPositive Net Change BYDDYPositive Net Change
auto-tires-trucks electric-vehicles